Overcoming BTK Resistance With Non-Covalent BTKi

This animation illustrates the role of BTK in B-cell cancer development, details mechanisms of resistance to covalent BTKi, and describes how non-covalent BTKi can overcome resistance to covalent agents in diseases such as chronic lymphocytic leukemia and mantle cell lymphoma. This is part of a CME/MOC/NCPD/CPE/AAPA/IPCE activity available at PeerView.com/GYD.